Drug Type Therapeutic vaccine |
Synonyms AFFITOPE AT04A+adjuvant, AT 04A, AT-04 + [2] |
Target |
Mechanism PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Phase 2 | AT | 19 Jul 2023 |
Phase 1 | 30 | lvnroagfcf(wuhpfcpaiz) = dgusfeidaa qmjuegohcb (qcrxhztplb ) | Positive | 01 Nov 2020 |